<DOC>
	<DOC>NCT00301379</DOC>
	<brief_summary>This is an observational study intended to validate results of a previous study done at the Mayo Clinic. Patients are treated with combination chemotherapy and radiation and maintained on oral Xeloda until they can receive liver transplant. A staging laparotomy is performed before chemoradiation in order to identify patients who will most benefit from the treatment and to improve outcomes.</brief_summary>
	<brief_title>Registry Study of Neoadjuvant Chemoradiation &amp; Transplant for Cholangiocarcinoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<criteria>1. Diagnosis of cholangiocarcinoma that has been established preoperatively by at least one of the following criteria: 1. A positive brush cytology or biopsy result obtained at the time of cholangiography; 2. Fluorescence in situ hybridization demonstrating aneuploidy; 3. A serum CA 199 value greater than 100 U/mL in the presence of a radiographically characteristic malignant stricture in the absence of cholangitis. 2. Tumor/stricture is above the cystic duct and is unresectable. 3. A suitable candidate for orthotopic liver transplantation as judged by a radiation oncologist, a medical oncologist, and the liver transplant team. 4. &gt;/= 18 years of age. 5. Willing and able to provide written informed consent. 1. Intrahepatic metastasis or other metastatic disease (except perihilar nodes). 2. Prior treatment for this disease (including attempts at resection, irradiation, or chemotherapy)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>Observational</keyword>
</DOC>